Thimerosal Use In Drugs Should Be Reconsidered, IoM Suggests
This article was originally published in The Tan Sheet
Executive Summary
FDA and professional societies should reconsider use of thimerosal-containing OTC nasal sprays by infants, children and pregnant women due to concerns about potential neurodevelopmental disorders, according to an Institute of Medicine report released Oct. 1.